Analytical Data
-
Gene name
FAM131C
- Application
-
Alternative Names
C1orf117; F131C_HUMAN; FAM131C; Family with sequence similarity 131; member C; FLJ36766; Gm693; Protein FAM131C
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96AQ9
-
Expression Region
1-280aa
-
AA Sequence
MGSCVSRDLFTSAHKNCPMPQGADPLNPDLPSGRTPTVAPDCVIGKDKQMDFCWDPWQRCFQTTNGYLSDSRSRPGNYNVAALATSSLVGVVQSIKDHITKPTAMAQGRVAHLIEWKGWSAQRAGWELSPAEDEHYCCLPDELREARFAAGVAEQFAITEATLSAWSSLDEEELHPENSPQGIVQLQDLESIYLQDSLPSGPSQDDSLQAFSSPSPSPDSCPSPEDPPSTAGIPQPPSPELQHRRRLPGAQGPEGGTHPPGSLPSMDSGSLWEEDEVFYN
-
Molecular Weight
56.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM131C is a gene that encodes a protein believed to play a significant role in cellular signaling and various biological processes. Recent studies have highlighted its potential involvement in important cellular pathways, including those related to cell proliferation, differentiation, and survival. Dysregulation of FAM131C has been linked to several pathological conditions, including cancer, making it a candidate for further investigation in therapeutic contexts. Researchers are particularly interested in recombinant forms of the FAM131C protein to facilitate detailed studies on its structure-function relationships and interactions with other cellular components. By producing and characterizing recombinant FAM131C, scientists aim to elucidate its mechanisms of action, contributing valuable insights into the molecular underpinnings of diseases where this protein may be implicated. This research not only has the potential to enhance our understanding of FAM131C's biological roles but also to pave the way for novel therapeutic approaches targeting pathways influenced by this protein. Overall, studying recombinant FAM131C can provide crucial data that may inform future drug development and intervention strategies in related diseases.
